Bonne Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Bonne has a total shareholder equity of ₩65.9B and total debt of ₩15.6B, which brings its debt-to-equity ratio to 23.6%. Its total assets and total liabilities are ₩90.3B and ₩24.4B respectively. Bonne's EBIT is ₩8.4B making its interest coverage ratio 3.7. It has cash and short-term investments of ₩15.0B.
Anahtar bilgiler
23.6%
Borç/özkaynak oranı
₩15.58b
Borç
Faiz karşılama oranı | 3.7x |
Nakit | ₩14.96b |
Eşitlik | ₩65.91b |
Toplam yükümlülükler | ₩24.36b |
Toplam varlıklar | ₩90.27b |
Son finansal sağlık güncellemeleri
Here's Why Bonne (KOSDAQ:226340) Can Manage Its Debt Responsibly
Jul 03Here's Why Bonne (KOSDAQ:226340) Can Manage Its Debt Responsibly
Mar 27Is Bonne (KOSDAQ:226340) Using Too Much Debt?
Nov 18Recent updates
Slammed 27% Bonne Co., Ltd. (KOSDAQ:226340) Screens Well Here But There Might Be A Catch
Sep 06Not Many Are Piling Into Bonne Co., Ltd. (KOSDAQ:226340) Stock Yet As It Plummets 27%
Jul 18Here's Why Bonne (KOSDAQ:226340) Can Manage Its Debt Responsibly
Jul 03Earnings Troubles May Signal Larger Issues for Bonne (KOSDAQ:226340) Shareholders
May 21Market Might Still Lack Some Conviction On Bonne Co., Ltd. (KOSDAQ:226340) Even After 25% Share Price Boost
May 02Here's Why Bonne (KOSDAQ:226340) Can Manage Its Debt Responsibly
Mar 27Bonne (KOSDAQ:226340) Share Prices Have Dropped 38% In The Last Year
Jan 12Is Bonne (KOSDAQ:226340) Using Too Much Debt?
Nov 18Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: A226340's short term assets (₩33.6B) exceed its short term liabilities (₩22.8B).
Uzun Vadeli Yükümlülükler: A226340's short term assets (₩33.6B) exceed its long term liabilities (₩1.6B).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: A226340's net debt to equity ratio (0.9%) is considered satisfactory.
Borcun Azaltılması: A226340's debt to equity ratio has increased from 3% to 23.6% over the past 5 years.
Borç Kapsamı: A226340's debt is well covered by operating cash flow (34.2%).
Faiz Kapsamı: A226340's interest payments on its debt are well covered by EBIT (3.7x coverage).